A review article on biochemical predictors of COVID-19 infection

The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 is centered on the unpredictable clinical course of the disease that can rapidly develop causing severe and deadly complications. The...

Full description

Bibliographic Details
Main Authors: Ria Lawrence, Amal Johnson, Raghupathi Narasimhan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Association of Pulmonologist of Tamil Nadu
Subjects:
Online Access:http://www.japt.in/article.asp?issn=2772-6355;year=2021;volume=4;issue=1;spage=27;epage=30;aulast=Lawrence
Description
Summary:The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 is centered on the unpredictable clinical course of the disease that can rapidly develop causing severe and deadly complications. The identification of effective laboratory biomarkers and being able to classify patients based on their risk is imperative in guaranteeing appropriate treatment. The analysis of recently published studies highlights the role of systemic vasculitis and cytokine-mediated coagulation disorders as the principal actors of multi-organ failure in patients with severe COVID-19 complications. In this review article, we will be discussing the role of biomarkers in the management of COVID-19 infection.
ISSN:2772-6355
2772-6363